These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23164506)

  • 1. Cardiac arrest and neuromuscular blockade reversal agents in the transplanted heart.
    Bertolizio G; Yuki K; Odegard K; Collard V; Dinardo J
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1374-8. PubMed ID: 23164506
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac arrest after neuromuscular blockade reversal in a heart transplant infant.
    Sawasdiwipachai P; Laussen PC; McGowan FX; Smoot L; Casta A
    Anesthesiology; 2007 Oct; 107(4):663-5. PubMed ID: 17893464
    [No Abstract]   [Full Text] [Related]  

  • 3. The Safety of Neuromuscular Blockade Reversal in Patients With Cardiac Transplantation.
    Barbara DW; Christensen JM; Mauermann WJ; Dearani JA; Hyder JA
    Transplantation; 2016 Dec; 100(12):2723-2728. PubMed ID: 26760570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular block and current treatment strategies for its reversal in children.
    Meretoja OA
    Paediatr Anaesth; 2010 Jul; 20(7):591-604. PubMed ID: 20642658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of neuromuscular blockade in ambulatory patients.
    Schreiber JU
    Curr Opin Anaesthesiol; 2014 Dec; 27(6):583-8. PubMed ID: 25251920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sugammadex to reverse neuromuscular blockade in a child with a past history of cardiac transplantation.
    Miller K; Hall B; Tobias JD
    Ann Card Anaesth; 2017; 20(3):376-378. PubMed ID: 28701612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
    Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
    Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of neuromuscular blocking agents: current practice.
    Nagelhout JJ
    AANA J; 2013 Dec; Suppl():8-11. PubMed ID: 24592527
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
    Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
    Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged cholinergic effects after the reversal of neuromuscular blockade with neostigmine.
    Carron M; Toniolo A; Ori C
    J Clin Anesth; 2016 Feb; 28():85. PubMed ID: 26239721
    [No Abstract]   [Full Text] [Related]  

  • 12. Prolonged neuromuscular block associated to non-alcoholic steatohepatitis in morbidly obese patient: neostigmine versus sugammadex.
    Carron M; Parotto E; Ori C
    Minerva Anestesiol; 2012 Jan; 78(1):112-3. PubMed ID: 22237790
    [No Abstract]   [Full Text] [Related]  

  • 13. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005-2013: A single center study.
    Belcher AW; Leung S; Cohen B; Yang D; Mascha EJ; Turan A; Saager L; Ruetzler K
    J Clin Anesth; 2017 Dec; 43():33-38. PubMed ID: 28972924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Have we learned how to relax our patients, by thinking outside the box?
    Lee C; Katz RL
    J Crit Care; 2009 Mar; 24(1):1-4. PubMed ID: 19272532
    [No Abstract]   [Full Text] [Related]  

  • 17. Neostigmine injected 5 minutes after low-dose rocuronium accelerates the recovery of neuromuscular function.
    Lederer W; Reiner T; Khuenl-Brady KS
    J Clin Anesth; 2010 Sep; 22(6):420-4. PubMed ID: 20868962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
    Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholinesterase blockers in anesthesiology: a replenishment of former arsenal].
    Buniatian AA; Stamov VI; Mizikov VM; Peĭkarova AV
    Anesteziol Reanimatol; 2011; (1):4-8. PubMed ID: 21513065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches to reversal of neuromuscular block.
    Bom A; Clark JK; Palin R
    Curr Opin Drug Discov Devel; 2002 Sep; 5(5):793-800. PubMed ID: 12630300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.